Tag Archives: DNA

AMC v. Myriad – “Laws of Nature” Exception Does Not Include Isolated DNA

Posted on July 31, 2011 by Warren Woessner

As noted in my last “flash” post, a divided three-judge Fed. Cir. panel (Judges Lourie, Bryson and Moore) issued an opinion holding that the isolated DNA sequences and the drug-screening method claimed by Myriad are patentable subject matter, not natural … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , | 2 Comments

Divided Panel Finds DNA Molecules Patentable – Cancer Screening Claims Too Abstract

Posted on July 29, 2011 by Warren Woessner

Today a divided Fed. Cir. panel of Judges Lourie, Moore and Bryson – Lourie writing for the “majority” – reversed the district court judge, in AMP v. Myriad, holding that isolated DNA sequences are patent-eligible subject matter and not natural … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , | Leave a comment

Decision of the EPO Enlarged Board of Appeal – Sexual Crossing and Selection of Plants is Not Patentable Even When Using DNA Markers

Posted on May 18, 2011 by Warren Woessner

The following is a contribution from Verena Simpson PhD of Zacco Denmark A/S. G 0001/08 The core of the Decision 1. A non-microbiological process for the production of plants which contains or consists of the steps of sexually crossing the … Continue reading →

Posted in EP and UK Practice | Tagged , , , , | Leave a comment

Patent System Fosters Eugenics – What Next?

Posted on April 27, 2011 by Warren Woessner

USA TODAY ran a provocative article yesterday (April 26, 2011) on the “dark past” of the respected journal Annals of Human Genetics, in which its editor, Andres Linares did a mea culpa for the role of the journal, founded in … Continue reading →

Posted in Stem Cells/Cloning | Tagged , , , , | Leave a comment